Mohr Marketing Targets High-Value NAION and Verified Gastroparesis Claims Amid New 2026 Medical Evidence
Mohr Marketing targets high-value NAION & Gastroparesis claims, using 2026 medical data to secure medically-vetted, signed GLP-1 cases. ALLENTOWN, PA, UNITED STATES, February 23, 2026 /EINPresswire.com/ -- As GLP-1 litigation enters a critical …